BTIG initiated coverage of NRx Pharmaceuticals (NRXP) with a Buy rating and $18 price target NRx Pharmaceuticals is working broadly in ...

Meeting to be held in Dallas on April 8 hosted by BTIG. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Fintel reports that on March 31, 2025, BTIG upgraded their outlook for Progyny (NasdaqGS:PGNY) from Neutral to Buy. Analyst ...

BTIG analysts highlighted a historical trend suggesting a potential rebound for the S&P 500 (SPX) in April following a ...

BTIG says Rocket Companies (RKT) is acquiring Mr. Cooper (COOP) in an all-stock deal valuing Cooper at roughly $143 ore share, plus a $2 cash ...

The S&P 500's recent breakdown below key technical levels suggests the market’s counter-trend rally may be over, said ...

Lululemon Athletica (NASDAQ:LULU – Free Report) had its price objective decreased by BTIG Research from $470.00 to $420.00 in ...